News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

November 2014

Top

Janssen seeks FDA approval for Yondelis drug to treat advanced STS
26 November 2014 Janssen Research & Development is seeking approval from US Food and Drug Administration (FDA) for its Yondelis (trabectedin) to treat patients with advanced soft tissue sarcoma...

Eisai opens new packaging facility for thyroid cancer treatment in UK
26 November 2014 Japan-based Eisai has opened a new global potent packaging facility for its investigational compound, lenvatinib, at the EMEA Knowledge Centre (EKC) in Hatfield,...

Merck and NewLink Genetics partner to develop Ebola vaccine candidate
25 November 2014 US-based pharmaceutical company Merck has signed an exclusive worldwide license agreement with NewLink Genetics to develop the latter's Ebola vaccine...

European Commission grants approval for Novartis's Signifor to treat acromegaly
25 November 2014 Swiss drug-maker Novartis has received approval from European Commission for its Signifor (pasireotide) intramuscular injection to treat adult patients suffering from acromegaly....

AbbVie buys active pharmaceutical ingredient (API) facility in Singapore
24 November 2014 US-based AbbVie has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Tuas Biomedical Park,...

AstraZeneca obtains European approval for Duaklir Genuair to treat COPD
24 November 2014 British-Swedish drugmaker AstraZeneca has received marketing approval from the European Commission (EC) for Duaklir Genuair (aclidinium bromide/formoterol fumarate...

Researchers create new AC inhibitor associated to melanoma, lung and prostate cancers
21 November 2014 Researchers from UC Irvine School of Medicine and the Italian Institute of Technology have created a novel inhibitor compound for enzymes linked to melanoma, lung and prostate...

Regeneron and Sanofi’s dupilumab gets FDA breakthrough therapy status for atopic dermatitis
21 November 2014 Regeneron Pharmaceuticals and Sanofi's dupilumab has received breakthrough therapy designation from US Food and Drug Administration (FDA) to treat adults with moderate-to-severe atopic...

Janssen seeks FDA approval for its antipsychotic drug to treat schizophrenia
20 November 2014 Janssen Research & Development has submitted a new drug application (NDA) for its three-month atypical antipsychotic paliperidone palmitate to the US Food and Drug Administration...

Mymetics’ virosome technology selected for MVI’s new malaria vaccine candidate
20 November 2014 Swiss biotechnology company Mymetics has been selected by PATH Malaria Vaccine Initiative (MVI) to develop and produce virosome-based vaccine formulations for a malaria transmission...

Bayer’s Eylea obtains Japanese approval to treat diabetic macular edema
19 November 2014 Bayer HealthCare has obtained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Eylea (aflibercept solution for injection) to treat patients with diabetic macular...

PHE survey reveals widespread misconceptions about antibiotics use in UK
19 November 2014 Research carried out by Public Health England (PHE) for European Antibiotic Awareness Day (EAAD) revealed widespread misconceptions about the use of antibiotics by the...

Actavis signs agreement to buy Botox-maker Allergan for $66bn
18 November 2014 Ireland-based pharmaceutical company Actavis has signed an agreement to acquire US-based Botox-maker Allergan for $66bn or $219 per...

UK grants new funding for five Ebola research projects in West Africa
18 November 2014 The UK Department for International Development (DFID) and the Wellcome Trust are providing £1.34m from a joint fund for five research projects, to combat the Ebola outbreak in West...

GSK launches first call for proposals for NCDs research in Africa
17 November 2014 GlaxoSmithKline (GSK) has launched the first call for proposals for its Africa NCD Open Lab to support scientific research into non-communicable diseases (NCDs) in...

AstraZeneca and Isis Pharmaceuticals partner for target oligonucleotides delivery methods
17 November 2014 British-Swedish drugmaker AstraZeneca has partnered with US-based Isis Pharmaceuticals to develop new delivery methods for antisense...

Pfizer agrees to supply contraceptive Sayana Press in poorer countries
14 November 2014 US-based drugmaker Pfizer has signed an agreement with Bill & Melinda Gates Foundation and Children's Investment Fund Foundation (CIFF) to expand access to its injectable contraceptive,...

BMS's sponsored programme selects four research projects to investigate viral diseases
14 November 2014 Bristol-Myers Squibb's (BMS) European medical education programme Partnering for Cure has selected four research projects, designed to investigate new ways to cure viral...

GSK seeks European approval for eltrombopag to treat severe aplastic anaemia
13 November 2014 British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag...

Servier to market Intarcia’s type 2 diabetes treatment outside US and Japan
13 November 2014 France-based pharmaceutical research company Servier has partnered with Intarcia Therapeutics to develop and commercialise its ITCA 650, outside the US and...

Takeda and GE Healthcare partner to develop therapeutic drugs for liver diseases
12 November 2014 Japan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic...